We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.91B
AUM Growth
-$2.79M
Cap. Flow
-$27.2M
Cap. Flow %
-0.93%
Top 10 Hldgs %
20.73%
Holding
3,310
New
248
Increased
388
Reduced
954
Closed
189

Top Buys

Rank Stock Value
1
FPE icon
First Trust Preferred Securities and Income ETF
FPE
+$6.56M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.36M
3
ILMN icon
Illumina
ILMN
+$3.21M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$3M
5
RBA icon
RB Global
RBA
+$2.93M

Top Sells

Rank Stock Value
1
PFFD icon
Global X US Preferred ETF
PFFD
+$5.94M
2
VST icon
Vistra
VST
+$5.92M
3
GDDY icon
GoDaddy
GDDY
+$5M
4
SMCI icon
Super Micro Computer
SMCI
+$4.37M
5
IVW icon
iShares S&P 500 Growth ETF
IVW
+$4M

Sector Composition

Rank Sector Weight
1 Technology 21.86%
2 Industrials 10.11%
3 Consumer Discretionary 9.49%
4 Financials 8.92%
5 Healthcare 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OUT icon
1226
Outfront Media
OUT
$5.29B
$210K 0.01%
14,906
– –
CNMD icon
1227
CONMED
CNMD
$1.49B
$210K 0.01%
3,023
-152
-5% -$11.1K
SNEX icon
1228
StoneX
SNEX
$8.37B
$209K 0.01%
9,369
– –
PSMT icon
1229
Pricesmart
PSMT
$5.49B
$209K 0.01%
2,572
– –
ENR icon
1230
Energizer
ENR
$1.56B
$208K 0.01%
7,045
-377
-5% -$10.9K
SYF icon
1231
Synchrony
SYF
$25.8B
$208K 0.01%
4,401
– –
LDOS icon
1232
Leidos
LDOS
$17.6B
$208K 0.01%
1,423
-112
-7% -$15.7K
IPAR icon
1233
Interparfums
IPAR
$3.78B
$207K 0.01%
1,786
-115
-6% -$14K
PFG icon
1234
Principal Financial Group
PFG
$24.4B
$207K 0.01%
2,638
– –
HNI icon
1235
HNI Corp
HNI
$3.55B
$207K 0.01%
4,591
– –
FFBC icon
1236
First Financial Bancorp
FFBC
$3.6B
$206K 0.01%
9,252
-507
-5% -$11.2K
AVDX
1237
DELISTED
AvidXchange
AVDX
$205K 0.01%
17,027
+2,177
+15% +$24.9K
AMBA icon
1238
Ambarella
AMBA
$3.66B
$205K 0.01%
3,803
– –
PTGX icon
1239
Protagonist Therapeutics
PTGX
$9.8B
$205K 0.01%
5,912
– –
NTLA icon
1240
Intellia Therapeutics
NTLA
$1.66B
$204K 0.01%
9,133
– –
CALX icon
1241
Calix
CALX
$2.51B
$204K 0.01%
5,759
-349
-6% -$11.2K
TDS icon
1242
Telephone and Data Systems
TDS
$4.03B
$204K 0.01%
9,837
– –
EPAC icon
1243
Enerpac Tool Group
EPAC
$1.91B
$203K 0.01%
5,328
-384
-7% -$14.2K
TDY icon
1244
Teledyne Technologies
TDY
$31.8B
$203K 0.01%
524
– –
ARE icon
1245
Alexandria Real Estate Equities
ARE
$8.27B
$203K 0.01%
1,738
– –
PRK icon
1246
Park National Corp
PRK
$3.72B
$203K 0.01%
1,425
– –
ULTA icon
1247
Ulta Beauty
ULTA
$22.9B
$203K 0.01%
525
– –
VRNT
1248
DELISTED
Verint Systems
VRNT
$202K 0.01%
6,288
– –
EQC
1249
DELISTED
Equity Commonwealth
EQC
$202K 0.01%
10,434
– –
APTV icon
1250
Aptiv
APTV
$10.2B
$202K 0.01%
2,863
-280
-9% -$21.5K
48 49
50
51 52

Similar funds

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return

Ameritas Investment Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Ameritas Investment Partners held 3,310 positions worth $2.91B, down 0.1% from $2.92B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Ameritas Investment Partners's Q2 2024 filing shows 248 new, 388 increased, 954 reduced and 189 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M. The largest sale was Global X US Preferred ETF, an estimated $5.94M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2024 buy was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M.
  • Ameritas Investment Partners added most to First Trust Preferred Securities and Income ETF in Q2 2024, an estimated $6.56M increase.
  • Ameritas Investment Partners's biggest Q2 2024 reduction was Global X US Preferred ETF, cutting an estimated $5.94M.
  • Ameritas Investment Partners fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $2.65M.
  • Ameritas Investment Partners's ten largest holdings make up 21% of its $2.91B portfolio in Q2 2024.
  • Ameritas Investment Partners opened 248 new positions and closed 189 in Q2 2024.
  • Ameritas Investment Partners's portfolio value fell 0.1% quarter-over-quarter to $2.91B.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.